Enovis CORP financial data

Symbol
ENOV on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
2711 Centerville Road, Suite 400, Wilmington, Delaware
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Colfax CORP (to 3/18/2022)
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 233 % +61.8%
Quick Ratio 122 % +86.5%
Debt-to-equity 38.3 % +41.5%
Return On Equity -2.4 % -60.7%
Return On Assets -1.74 % -47.4%
Operating Margin -4.17 % -1.46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.9 M shares +0.65%
Common Stock, Shares, Outstanding 54.8 M shares +0.64%
Entity Public Float 3.48 B USD +29.6%
Common Stock, Value, Issued 55 K USD +1.85%
Weighted Average Number of Shares Outstanding, Basic 54.7 M shares +0.67%
Weighted Average Number of Shares Outstanding, Diluted 54.7 M shares +0.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.02 B USD +16.4%
Revenue from Contract with Customer, Excluding Assessed Tax 1.82 B USD +14%
Research and Development Expense 80.5 M USD +25.5%
Operating Income (Loss) -75.8 M USD -15.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -116 M USD -2156%
Income Tax Expense (Benefit) -13.6 M USD -147%
Net Income (Loss) Attributable to Parent -81.9 M USD -58.4%
Earnings Per Share, Basic -1.32 USD/shares -207%
Earnings Per Share, Diluted -1.5 USD/shares -56.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 66.3 M USD +203%
Accounts Receivable, after Allowance for Credit Loss, Current 381 M USD +35.7%
Inventory, Net 586 M USD +33.5%
Other Assets, Current 81.4 M USD +33.3%
Assets, Current 1.15 B USD +38.1%
Property, Plant and Equipment, Net 346 M USD +40.5%
Operating Lease, Right-of-Use Asset 70.1 M USD +10.3%
Intangible Assets, Net (Excluding Goodwill) 1.41 B USD +30.2%
Goodwill 2.41 B USD +21.5%
Other Assets, Noncurrent 89.2 M USD +1.5%
Assets 5.48 B USD +27.4%
Accounts Payable, Current 156 M USD +2.64%
Employee-related Liabilities, Current 128 M USD +171%
Accrued Liabilities, Current 373 M USD +88.8%
Liabilities, Current 549 M USD +57.1%
Other Liabilities, Noncurrent 249 M USD +46.1%
Liabilities 2.17 B USD +154%
Accumulated Other Comprehensive Income (Loss), Net of Tax -65.4 M USD -52.5%
Retained Earnings (Accumulated Deficit) 470 M USD -14.8%
Stockholders' Equity Attributable to Parent 3.31 B USD -3.92%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.31 B USD -3.9%
Liabilities and Equity 5.48 B USD +27.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.2 M USD -585%
Net Cash Provided by (Used in) Financing Activities 865 M USD +3429%
Net Cash Provided by (Used in) Investing Activities -798 M USD -2220%
Common Stock, Shares Authorized 133 M shares 0%
Common Stock, Shares, Issued 54.8 M shares +0.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.7 M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 16.3 M USD -56%
Deferred Tax Assets, Valuation Allowance 102 M USD +8.67%
Operating Lease, Liability 66.2 M USD -4.62%
Payments to Acquire Property, Plant, and Equipment 36.9 M USD +21.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -104 M USD -198%
Lessee, Operating Lease, Liability, to be Paid 71.7 M USD -5.56%
Property, Plant and Equipment, Gross 513 M USD +22.8%
Operating Lease, Liability, Current 6.59 M USD -71.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.4 M USD +7.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.5 M USD -12.6%
Deferred Income Tax Expense (Benefit) -9.97 M USD -1299%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.51 M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.4 M USD +6.43%
Deferred Tax Assets, Operating Loss Carryforwards 37.4 M USD -1.39%
Current Income Tax Expense (Benefit) 14.1 M USD +16.3%
Unrecognized Tax Benefits 32.1 M USD -16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.4 M USD -18.6%
Additional Paid in Capital 2.9 B USD -1.04%
Current State and Local Tax Expense (Benefit) 4.18 M USD -15.7%
Current Federal Tax Expense (Benefit) 949 K USD -74.9%
Amortization of Intangible Assets 142 M USD +11.6%
Depreciation, Depletion and Amortization 6.43 M USD -15.4%
Deferred Tax Assets, Net of Valuation Allowance 227 M USD +2.25%
Share-based Payment Arrangement, Expense 31.6 M USD -0.39%
Interest Expense 34.1 M USD +50.6%